-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
TC BioPharm (Holdings) plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2022 to Q4 2023.
- TC BioPharm (Holdings) plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was £4.45M, a 7.44% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (GBP)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)